05 Compliance

Where MCT oil is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-20 · MCT Oil

On this page
  1. Three markets, three instruments
  2. European Union
  3. United States
  4. Contaminants and the limits that matter
  5. Where the claim line sits
  6. The file a buyer should hold
  7. A launch checklist

MCT oil is a food ingredient with a history of use, and it can be supplied as an ingredient for food supplements in the EU, the US and the UK. Permission is rarely the obstacle. The file is: the source oil and its allergen position, the process-contaminant data for a refined lauric oil, the label declaration and the claim wording decide whether the file supports the label. The buyer's regulatory team confirms the route for the destination.

In one line

MCT oil is a food ingredient in all three markets; the source statement, the process-contaminant data and the claim wording are what decide whether the file supports the label.

Three markets, three instruments

The EU regulates the oil under general food law and, in dose form, under the food supplements directive. The US regulates a supplement under DSHEA and the cGMP rules for dietary supplements, and a conventional food under the food rules. The UK applies retained law in Great Britain, with Northern Ireland following the EU regime. In every market the ingredient status and the finished-product status are separate questions, and the label rules follow the finished product.

These statements are a summary as of this review. Contaminant limits, labelling guidance and claim lists change; check the current text before a launch.

European Union

In the EU, the oil is used as a food ingredient and as a carrier for fat-soluble nutrients; the exact source and process are part of the file the buyer's team reviews. Directive 2002/46/EC sets the supplement framework, Regulation 1169/2011 the label, Regulation 1924/2006 the claims and Regulation 2023/915 the contaminant limits. The nutrition declaration carries fat and saturates, using the 9 kcal/g conversion factor for fat; the C8/C10 split is not a nutrition line.

The source matters for the allergen file. Coconut and palm kernel are not on the EU Annex II list, which does not remove the need for a source statement and does not cover a carrier or a processing aid. A coconut-derived MCT is not automatically an allergen issue in the EU, but the label still has to name the ingredient accurately, and the source statement is what a customer audit asks for.

If the oil is supplied as a carrier in a supplement, the finished product's status is the question, not the oil's. The specification and the source statement belong in the file either way.

United States

In the US, the first question is whether the oil is used in a dietary supplement or in a conventional food. A supplement sits under DSHEA, with cGMP in 21 CFR 111 and labelling in 21 CFR 101; a conventional food follows the food rules. The Supplement Facts panel carries fat and saturated fat, and the ingredient statement names the oil. The C8/C10 split is a specification and ingredient-description point, not a nutrition line.

Coconut is classified as a tree nut for US labelling. A highly refined oil derived from coconut may fall within the refined-oil exemption, but the supplier has to document the basis rather than leave the buyer to assume it. If the source is palm kernel, the tree-nut question does not arise, but the source statement still belongs in the file.

Structure/function statements are permitted for a supplement with the required disclaimer, and they must be truthful and not misleading. A disease claim is not permitted. The line between the two is a labelling question, and it is reviewed before the artwork is final.

Contaminants and the limits that matter

The catalog panel is a release gate, not a statement of every legal limit. The limit that applies depends on whether the oil is sold as a supplement or used in a conventional food, and on the market.

Catalog limits and what the buyer still has to check
ParameterCatalog limitWhat to check
Lead≤3 mg/kgFinished-product limit for the market and category
Arsenic≤2 mg/kgMarket limit or customer specification
Cadmium≤1 mg/kgFinished-product limit for the market and category
Mercury≤0.1 mg/kgFinished-product limit for the market and category
Peroxide value≤1.0 meq O₂/kgShelf-life headroom, not only release
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentFinished-product specification and market guidance

A refined lauric oil also has process contaminants: 3-MCPD and its esters, glycidyl esters, and the PAH panel where the source makes it relevant. These are not routine lines on the catalog COA; they are questions for the supplier's food-safety file, and the current text of Regulation 2023/915 is the EU reference.

Where the claim line sits

The defensible statements about the oil are compositional: the C8/C10 ratio, the source, the fat content and the physical form. Each can be checked against the COA and the specification. A statement about what the oil does in the body is a different category, and it needs the evidence and the wording that the market allows.

In the EU, a claim must be on the permitted list and must not be a disease claim. In the US, a structure/function statement needs substantiation and the DSHEA disclaimer, and a disease claim is not permitted. “Keto” is a diet description, not an authorised claim, and a statement that MCT burns fat is a health promise the file will not support. This site publishes specifications only; it offers no health claim.

The file a buyer should hold

A market-ready file usually contains the specification, the batch COA, the technical data sheet, the safety data sheet, the source and allergen statement, the heavy-metal and microbiology results, the process-contaminant data, the shelf-life statement and the storage condition, a process flow chart and the lot traceability record. Add a GMO statement, a halal or kosher certificate or a country-of-origin declaration where the market or the customer asks for it.

The file should be internally consistent. The C8 and C10 ranges on the COA, the TDS and the label should be the same. The source named on the TDS should be the source in the allergen review. The lot code should match the drum, the bottle and the retained sample. Inconsistency is a common reason a file fails a customer audit, not a missing document.

A launch checklist

  • Confirm the market and whether the product is a supplement or a conventional food.
  • Name the oil source and check the allergen position for that source.
  • Check the contaminant limits against the finished product, not only the oil.
  • Ask for the 3-MCPD, glycidyl ester and PAH data where the oil is refined.
  • Match the nutrition declaration to the fat content and the serving size.
  • Review every claim against the permitted list and the evidence.
  • Match the lot code across COA, pack and retained sample.
  • File the TDS, SDS, COA, allergen statement and shelf-life data together.

The catalog specification is on the MCT oil product page, and the carrier form is on the MCT powder page. The COA page explains the certificate lines; the MOQ page covers the order file; the identity page covers the C8/C10 evidence. The market summaries are on the EU, US and UK pages; the quality page describes the release route; the methods section covers the analytical tests.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation